Mr. Camargo has a strong international background in the healthcare sector, including pharma and generics, biotechnology, cell biology and life sciences, animal health and veterinary medicine, consume healthcare and health insurance. From his university background, Ruy Camargo is a bachelor of business administration with a MBA from Manchester business School / United Kingdom and specialization in marketing and innovation for pharma at IESE business school in Spain.
Mr. Camargo has a professional background of more than 20 years both in FMCG (Fast Moving Consumer Goods), Consumer Health, RX Pharmaceuticals and Animal Health, as well as, biotechnology. He worked through various assignments in leadership positions managing global brands in the cosmetics, hygiene and beauty products with focus in Latin America. In the healthcare sector, his expertise focused in consumer healthcare specially in branded generics with Abbott Laboratories both in Switzerland, Mexico & Brazil but also in leading roles in animal health at Pfizer and managing veterinary medicine operations at Ourofino of Mexico as General Manager. As an investor, he participates as member of the board of directors of a global network of startups, entrepreneurs and innovators (Impact Hub) and biotech company in the stem cell biology area. He also participated in projects in the health insurance and market access sector.
He is a subject matter expert for topics associated with Consumer Goods, Consumer Health, Rx Pharma, Animal health and Veterinery Medicine, Biotechnology and Health Insurance